15-65003120-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_139242.4(MTFMT):c.1112G>A(p.Arg371Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,612,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_139242.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MTFMT | NM_139242.4 | c.1112G>A | p.Arg371Lys | missense_variant | 9/9 | ENST00000220058.9 | |
MTFMT | XM_005254158.6 | c.1265G>A | p.Arg422Lys | missense_variant | 9/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MTFMT | ENST00000220058.9 | c.1112G>A | p.Arg371Lys | missense_variant | 9/9 | 1 | NM_139242.4 | P1 | |
MTFMT | ENST00000558460.5 | c.1112G>A | p.Arg371Lys | missense_variant, NMD_transcript_variant | 9/10 | 5 | |||
MTFMT | ENST00000560717.5 | c.*582G>A | 3_prime_UTR_variant, NMD_transcript_variant | 8/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151982Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248442Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134804
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460380Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726378
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151982Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74194
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | The c.1112G>A (p.R371K) alteration is located in exon 9 (coding exon 9) of the MTFMT gene. This alteration results from a G to A substitution at nucleotide position 1112, causing the arginine (R) at amino acid position 371 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 29, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The lysine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with MTFMT-related conditions. This variant is present in population databases (rs771526888, gnomAD 0.009%). This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 371 of the MTFMT protein (p.Arg371Lys). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at